Literature DB >> 15630748

Mycophenolate mofetil induced myopathy in a patient with lupus nephritis.

María Galindo1, Ana Cabello, Beatriz Joven, Ana Alonso, Patricia Carreira, Jesús Porta, José Ramón Ricoy, Isabel Mateo, José L Pablos.   

Abstract

We describe a case of mycophenolate mofetil (MMF) induced myopathy in a patient with lupus nephritis. Two months after starting MMF treatment she developed asthenia, lower limb weakness, and abnormal increase of muscle enzymes. An electromyogram showed a myogenic pattern with small polyphasic discharges without neurogenic signs involving proximal muscles of lower limbs. Muscle biopsy revealed the presence of fibers of variable size with irregular sarcoplasmic basophilic areas. Using oxidative enzyme techniques, many type I fibers showed a moth-eaten appearance resembling minicores. The ultrastructural findings consisted of myofibrillary lesions with multiple small foci of Z-band streaming. MMF withdrawal was followed by complete clinical and enzymatic recovery.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15630748

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  4 in total

1.  Systemic inflammatory response in a liver transplant recipient: a potential side effect of mycophenolate mofetil.

Authors:  Rebecca Smith; Adam Testro
Journal:  BMJ Case Rep       Date:  2018-03-28

Review 2.  Mycophenolate mofetil in the treatment of systemic lupus erythematosus.

Authors:  Ali Sahin
Journal:  Eurasian J Med       Date:  2009-12

Review 3.  Sarcopenia and liver transplant: The relevance of too little muscle mass.

Authors:  Eric R Kallwitz
Journal:  World J Gastroenterol       Date:  2015-10-21       Impact factor: 5.742

4.  Immune-mediated necrotizing myopathy, associated with antibodies to signal recognition particle, together with lupus nephritis: case presentation and management.

Authors:  John O'Grady; Len Harty; Nick Mayer; Val Critcher; John Ryan
Journal:  J Clin Med Res       Date:  2015-04-08
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.